Why VBI Vaccines Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
$ADD
$AKU
$ALLR
$AVTX
Engineering & Construction
Consumer Discretionary
Medical Specialities
Health Care
Gainers
- Akumin Inc. (NASDAQ:AKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar as President and Chief Operating Officer of the Company.
- Mullen Automotive, Inc. (NASDAQ:MULN) shares gained 52.8% to $0.2612 in pre-market trading. Mullen Automotive shares jumped 69% on Wednesday after the company announced the retention of a law group to investigate possible naked short selling.
- Micromobility.com Inc. (NASDAQ:MCOM) shares rose 19.8% to $0.1354 in pre-market trading. micromobility.com recently announced a strategic realignment to strengthen its financial position and drive profitability.
- Caravelle International Group (NASDAQ:CACO) rose 19.6% to $0.6399 in pre-market trading.
- AIM ImmunoTech Inc. (NYSE:AIM) gained 18.3% to $0.7690 in pre-market trading after declining 3% on Wednesday.
- Histogen Inc. (NASDAQ:HSTO) rose 18% to $0.8563 in pre-market trading. Histogen announced its decision to pause further development of its programs and commence a process to explore strategic alternatives.
- IGC Pharma, Inc. (NYSE:IGC) shares rose 14.7% to $0.39 in pre-market trading after gaining around 5% on Wednesday.
- IronNet, Inc. (NYSE:IRNT) shares climbed 13.9% to $0.2392 in pre-market trading after gaining 6% on Wednesday.
- Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares gained 11.8% to $0.4025 in pre-market trading. Avalo Therapeutics recently said its Phase 2 Peak trial for quisovalimab In patients with non-eosinophilic asthma missed its primary endpoint.
- Aurora Mobile Limited (NASDAQ:JG) gained 7.2% to $0.3112 in pre-market trading. Aurora Mobile secured approval to transfer to Nasdaq Capital Market.
Losers
- Allarity Therapeutics, Inc. (NASDAQ:ALLR) fell 26.9% to $6.05 in pre-market trading. Allarity Therapeutics shares jumped 31% on Wednesday after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in DRP-selected metastatic breast cancer patients.
- VBI Vaccines Inc. (NASDAQ:VBIV) fell 23.5% to $1.85 in pre-market. VBI Vaccines and Brii Biosciences announced the expansion of their hepatitis B partnership. The company also reported proposed concurrent public offering and registered direct offering of common shares and warrants.
- Tattooed Chef, Inc. (NASDAQ:TTCF) fell 18.7% to $0.2334 in pre-market trading. Tattooed Chef recently announced it intends to file for voluntary Chapter 11 Bankruptcy protection.
- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) fell 16.8% to $0.2069 in pre-market trading after the company received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the 6-month extension period granted by Nasdaq, and hence the company's shares will be suspended from trading on NASDAQ at the open of business on July 7, 2023.
- Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) shares dropped 14.3% to $0.5001 in pre-market trading after gaining over 12% on Wednesday.
- Senti Biosciences, Inc. (NASDAQ:SNTI) fell 12.3% to $0.5910 in pre-market trading after adding over 5% on Wednesday.
- Guardion Health Sciences, Inc. (NASDAQ:GHSI) shares fell 12.2% to $7.00 in pre-market trading. Guardion Health Sciences recently named Jan Hall as President and Chief Executive Officer.
- Calliditas Therapeutics AB (NASDAQ:CALT) fell 11.2% to $15.80 in pre-market trading after gaining around 13% on Wednesday.
- Color Star Technology Co., Ltd. (NASDAQ:ADD) fell 10.7% to $1.20 in pre-market trading. Color Star Technology recently said that its subsidiary, Color Metaverse Pte. Ltd, has entered into a strategic cooperation framework agreement with Beijing Zhong Guang Shi Xun International Cultural Development Co., Ltd. in order to further develop its business in the Asia live events market in the future.
- Greenbrook TMS Inc. (NASDAQ:GBNH) shares dropped 10.1% to $0.6205 in pre-market trading. Greenbrook TMS recently reported the acceptance of Mr. Benjamin Klein's resignation from the board of directors of the Company.
Now Read This: Investor Optimism Improves Slightly Following Fed Minutes
